Nantahala Capital Management - AEROVATE THERAPEUTICS INC ownership

AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 71 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of AEROVATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,289,150
-20.9%
95,0000.0%0.11%
-30.4%
Q2 2023$1,629,250
-15.0%
95,0000.0%0.16%
+7.5%
Q1 2023$1,916,150
+316.5%
95,000
+505.1%
0.15%
+390.0%
Q4 2022$460,01015,7000.03%
Other shareholders
AEROVATE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 603,762$8,193,05018.42%
TCG Crossover Management, LLC 2,201,274$29,871,2884.40%
Atlas Venture Life Science Advisors, LLC 2,039,249$27,672,6094.29%
Sofinnova Investments, Inc. 3,758,686$51,005,3693.22%
GREAT POINT PARTNERS LLC 1,091,233$14,808,0322.70%
RA Capital Management 8,263,982$112,142,2362.21%
Cormorant Asset Management, LP 1,561,696$21,192,2151.24%
Frazier Life Sciences Management, L.P. 1,204,867$16,350,0451.09%
Octagon Capital Advisors LP 497,370$6,749,3111.04%
Ghost Tree Capital, LLC 201,197$2,730,2430.90%
View complete list of AEROVATE THERAPEUTICS INC shareholders